Medtronic plc Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Medtronic plc quarterly/annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and growth rate from Q2 2019 to Q2 2024.
  • Medtronic plc Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending July 26, 2024 was $27M.
  • Medtronic plc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was -$259M, a 88.1% increase from 2022.
  • Medtronic plc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was -$2.17B, a 1894% decline from 2021.
  • Medtronic plc annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2021 was $121M.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $27M +$231M Apr 27, 2024 Jul 26, 2024 10-Q 2024-08-27
Q2 2023 -$204M +$1.37B +87% Apr 29, 2023 Jul 28, 2023 10-Q 2024-08-27
Q2 2022 -$1.57B -$985M -167% Apr 30, 2022 Jul 29, 2022 10-Q 2023-08-31
Q2 2021 -$589M -$2.95B -125% May 1, 2021 Jul 30, 2021 10-Q 2022-09-01
Q2 2020 $2.36B +$1.67B +243% Apr 25, 2020 Jul 31, 2020 10-Q 2021-09-02
Q2 2019 $687M Apr 27, 2019 Jul 26, 2019 10-Q 2020-09-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.